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Abstract
Background MicroRNAs, targeting mRNAs of cancer-as-
sociated genes, are often aberrantly expressed in human
gastric cancer (GC).
Aim We have examined the possible role and mechanisms
of miRNA regulation of Prdx-6 in the development and
progression of H. pylori-related gastric mucosal lesions.
Methods First, miR-24-3pwas predicted to target Prdx-6, and
this negative regulation was validated by luciferase reporter
analyses, Western blot, and quantitative RT-PCR. Next,
immunohistochemistry and in situ hybridization were per-
formed to detect thePrdx-6 andmiR-24-3p expression in tissue
microarrays of gastricmucosal lesions. Finally, themiR-24-3p
function in GC cell line N87 was examined byMTT, Annexin
V-FITC,PI, transwellmigration, andMatrigel invasionassays.
Results In our study, Prdx-6 expression was negatively reg-
ulated by miR-24-3p expression and miR-24-3p interacted
with the 30-untranslated region of Prdx-6 to down-regulate its
expression level. In addition, miR-24-3p expression gradu-
ally decreased in human gastric specimens from chronic
superficial gastritis (CSG) to dysplasia and was upregulated
in GC tissues compared with adjacent normal tissues. Con-
trary to this, Prdx-6 expression showed inverse tendency in
the same tissue. More so, expression of miR-24-3p was
reduced in samples with H. pylori infection, especially in
CSG. Moreover, miR-24-3p was associated with GC lymph
nodes and liver metastasis. Gain- or loss-of-function experi-
ments showed thatmiR-24-3p significantly inhibitedN87 cell
growth, migration, and invasion and promoted apoptosis,
while Prdx-6 reversed these miR-24-3p effects.
Conclusions miR-24-3p was identified as a regulator of
development and progression of H. pylori-related gastric
mucosal lesions.
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Introduction
MicroRNAs (miRNAs) are a novel class of endogenous,
small noncoding RNAs that negatively regulate gene
expression by perfect or imperfect base pairing with the
30-untranslated region (UTR) of mRNAs [1]. MiRNAs
play important roles in numerous biological processes,
including cell development, apoptosis, and proliferation
[2, 3]. Aberrant expression of miRNAs is involved in
various cancers, including gastric cancer (GC), which is
the second leading cause of tumor-related deaths world-
wide [4]. Therefore, revealing the role of miRNAs in
gastric cancer tumorigenesis may provide novel targets
for prevention and treatment. Peroxiredoxins (Prdxs) are a
family of small proteins that catalyze the reduction in
peroxides using their conserved cysteine (Cys) residues as
catalytical centers [5, 6]. Peroxiredoxin 6 (Prdx-6),
belonging to the class of 1-Cys Prdx, plays an important
role in neutrophil function and supports the optimal
activity of Nox2 [7].
In our previous study, it was shown that Prdx-6 was
associated with the development and progression of H.
pylori-related gastric mucosal lesions [8]. In addition,
bioinformatics prediction indicated that there are five
miRNAs that might regulate Prdx-6 expression level (hsa-
miR-24, hsa-miR-186, hsa-miR-149, hsa-miR-124, and
hsa-miR-506). Based on the integrated analysis of copy
number variations (CNVs), genomic alterations, miRNA
expression profiling, microRNA 24 drew our attention and
it has two gene subtypes—miR-24-3p, miR-24-5p [9].
After preliminary experiments, miR-24-3p was found to be
highly expressed in GC. In this study, it is hypothesized
that miR-24-3p might influence the development and pro-
gression of gastric mucosal lesions as well as tumorigenic
properties of GC cell lines via Prdx-6.
Materials and Methods
Human Tissue Specimens and Tissue Microarray
Paraffin-embedded tissue samples, including 35 chronic
superficial gastritis (CSG) samples, 43 chronic atrophic
gastritis (CAG) samples, 41 intestinal metaplasia (IM)
samples, 39 dysplasia (Dys) samples, 31 human GC sam-
ples, and 31 samples from adjacent normal mucosal tissues,
were included in this study. Resected tissues from 31
patients with GC were harvested at the Department of
Surgery, while other specimens were collected from
patients undergoing gastroscopy at the Department of
Gastroenterology, Aerospace Center Hospital, from 2005
through 2012. None of the GC patients had received
adjuvant chemotherapy before surgery. All samples were
verified by pathological examination and were used for a
tissue microarray. Clinicopathological data were reviewed,
and TNM staging classification was based on the American
Joint Committee on Cancer criteria (UICC/AJCC, 7th
edition). Written informed consent from the donor was
obtained for the use of this sample in research. The study
was approved by the Ethics Committee of Aerospace
Center Hospital (20140627YJS-01).
Cell Lines and Cell Culture
All cell lines were preserved in our laboratory, and these
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, Grand Island, NY, USA.) with 10 %
fetal bovine serum (FBS) (Invitrogen, Grand Island, NY,
USA) and incubated in a humidified incubator (5 % CO2)
at 37 C.
Plasmid Construction and Cell Transfection
The expression plasmids containing miR-24-3p and Prdx-6
sequences were created by polymerase chain reaction
(PCR) amplification using human genomic DNA as a






GTGTAGCGGAGG-30. The PCR products were cloned
into the pcDNA3.1(-) expression vector (Invitrogen,
Grand Island, NY, USA) and confirmed by DNA
sequencing. The empty vector was used as a control.
N87 cells were seeded at 1000 cells per well in six-well
plates. Cells were transfected with miR-24-3p or empty
vector using Lipofectamine 2000 (Invitrogen, Grand
Island, NY, USA). Twenty-four hours after transfection,
the transfected cells were incubated for 3 weeks in DMEM
with 400 lg/ml of G418 (Glenview, IL, USA). Next, Prdx-
6 expression vectors were transiently transfected into N87
cells overexpressing miR-24-3p or N87 cells transfected
with an empty vector.
The hsa-miR-24-3p mimics, inhibitor, and their negative
controls were purchased from Invitrogen (Shanghai,
China). Oligonucleotide transfection was performed with
Lipofectamine 2000 reagent at a final concentration of
100 nmol/l.
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Luciferase Reporter Assay
To generate the 30-UTR luciferase reporter, the full length
of the Prdx-6 30-UTR sequence was cloned into the
downstream region of the firefly luciferase gene using the
pmirGLO Dual-luciferase miRNA Target Expression
Vector (Promega, Madison, WI, USA; E1910). Mutant
miR-24-3p target sites in the Prdx-6 30-UTR sequence were
used as corresponding controls. N87 and AGS Cells were
seeded in triplicate in 24-well plates and cultured for 24 h.
Luciferase reporter vectors were cotransfected with miR-
24-3p mimic or negative control (NC) using Lipofectamine
2000. Luciferase activities were measured 24 h after
transfection using the Dual-Luciferase Reporter Assay
System (Promega). Two independent experiments were
performed in triplicate. Firefly luciferase activity was
normalized against Renilla luciferase activity.
Quantitative Reverse Transcription PCR (RT-
qPCR)
Total RNA was extracted from cells using a standard Trizol
protocol (Invitrogen). Reverse transcription (RT) reactions
were carried out using EasyScript First-Strand cDNA
Synthesis SuperMix (TransGen Biotech, Beijing, China),
and stem-loop RT primer for miR-24-3p was: GTC
GTATCCAGTGCAGGGTCCGAGGTATTCGCACTGG
ATACGACCTGTTC. The miRNA expression level was
evaluated using the miRNA Q-PCR Detection Kit (Gene-
Copoeia, Rockville, MD, USA) according to the manu-
facturer’s protocol. Expression of miR-24-3p and Prdx-6
was detected using the SYBR Green method, and primers
for miR-24-3p and Prdx-6 were: 50-TTTGGCTCAGTT
CAGCAG-30 (F), 50-TTTGGCACTAGCACATT-30
(R) and 50-GGATGGGGATAGTGTGATGG-30 (F), 50-CT
GACATCCTCTGGCTCACA-30 (R).The results were
normalized against U6 and b-actin.
Western Blot Analysis
Total proteins were extracted from cell lines in lysis buffer
containing 50 mM Tris (pH 6.8), 100 mM dithiothreitol,
1 % sodium dodecyl sulfate, and 25 % glycerol. Equal
amount of proteins were electrophoresed by 12 % SDS–
polyacrylamide gel electrophoresis and transferred to
polyvinylidene fluoride (PVDF) membranes using the
Mini-PROTEAN 3 system (Bio-Rad, Hercules, USA).
PVDF membranes were blocked in 5 % bovine serum
albumin and incubated with rabbit antihuman Prdx-6
polyclonal antibody (1:2000; Abcam, Cambridge, MA,
USA) followed by horseradish peroxidase-linked goat–
antimouse IgG (Proteintech, Chicago, IL, USA). b-Actin
was used as a loading control (Sigma, St. Louis, MO,
USA). Protein intensity was quantified using the LANE 1D
Analyzer software (Sage Creation, Beijing, China).
Immunohistochemistry (ICH) and In Situ
Hybridization (ISH)
Tissue microarrays were stained with rabbit antihuman
Prx-6 polyclonal antibody (1:1000; Abcam, Cambridge,
MA, USA). IHC staining was performed using Envision kit
(Dako, Glostrup, Denmark).
The sequence of the miR-24-3p probe was 50-
CTGTTCCTGCTGAACTGAGCCA-30 (miRCURY TM probe,
Exiqon, Vedbaek, Denmark). A U6 probe (sequence:
CACGAATTTGCG TGTCATCCTT; Exiqon) was used as
the positive control. ISH was implemented according to the
guidelines stated in the miRCURY LNA microRNA ISH
Optimization Kits (FFPE) protocol (Exiqon). Slides were
treated with proteinase K at 15 lg/ml for 10 min at 37 C.
Hybridization was performed at 62 and 58 C, respectively,
for the following: 50-digoxigenin (DIG) labeled (U6) and
double DIG (miR-24-3p), LNA-modified oligonucleotide
ISH probes.
MTT Assay
N87 transfected and control cells were seeded in 96-well
plates with 1 9 104 cells per well in 100 ll of cell culture
medium, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylter-
trazolium bromide (MTT) was added at 0, 24, 48, 72, and
96 h. After 4 h incubation at 37 C in 5 % CO2, 200 ll of
dimethyl sulfoxide (DMSO) was added to solubilize the
formazan product. The absorbance at 570 nm was deter-
mined using a microplate reader (Bio-Rad, Hercules, USA).
Apoptosis Analysis
The Annexin V-FITC Apoptosis Detection Kit (Beijing Bio-
sea Biotechnology Co., Ltd., Beijing, China) was used to
examine cell apoptosis. Inbrief, trypsinizedcellswere double-
stained with fluorescein isothiocyanate (FITC)-conjugated
Annexin V (20 lg/ml) and propidium iodide (PI; 50 lg/ml)
according to the manufacturer’s protocol. Cells (1x104 per
well) were detected by FACSorter flow cytometer (BD, New
Jersey, USA), and data were analyzed using FASCDiva
software. Cells in the early stages of apoptosis were Annexin
V-positive and PI-negative, whereas cells in the late stages of
apoptosis were both Annexin V- and PI-positive.
Migration and Invasion Assay
For the migration assay, cells at a concentration of 5 9 104
cells/ml were plated onto six-well transwell plates (Corn-
ing, Tewksbury, MA, USA) with an 8.0-lm pore
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polycarbonate membrane. For the invasion assay, cells
(5 9 104 cells/ml) were plated onto six-well transwell
plates pre-coated with Matrigel (BD, Shanghai, China). In
both assays, DMEM containing 10 % FBS was used as a
chemoattractant and was added to the lower chamber. After
24 and 48 h, membranes were fixed with 95 % alcohol for
20 min and stained with hematoxylin for 10 min. Six
random fields for each insert were counted, and the results
were averaged among three independent experiments.
Statistical Analysis
All of the enumerated data were analyzed by the v2 and
Fisher’s exact tests, and comparisons of the continuous data
between two groups were analyzed using the Student’s t test
when there were only two groups. Data are expressed as the
mean ± SD or percentage and constituent ratio. All statis-
tical analyses were performed using SPSS software (version
17.0, IBM, USA) and P\ 0.05 or P\ 0.05/10 (Bonferroni
correct P value) was considered statistically significant.
Results
miR-24-3p Was Identified as an Upstream miRNA
of Prdx-6 by miRNA Selection
For the selection of miRNAs potentially targeting Prdx-6 to
be included in subsequent analysis, TargetScan 6.2 soft-
ware (http://genes.mit.edu/targetscan/index.html) was
used. Based on the June 2012 release version, five micro-
RNAs were found that potentially targeted Prdx-6. Next, an
integrated analysis was performed, which included exam-
ination of publicly available data on miRNA expression
profiling, CNVs, genomic alterations [8], and in our pre-
liminary experiments, miR-24-3p was identified as an
upstream miRNA of Prdx-6.
Negative Regulation Between miRNA-24-3p
and Prdx-6 Expression Is Present in Gastric Cancer
Cells
To investigate the expression of miRNA-24-3p and Prdx-6,
RT-qPCR and Western blot were performed in five types of
GC cell lines (BGC823, MGC803, SGC7901, AGS, and
N87) and one immortalized normal gastric mucosal
epithelial cell line (GES-1). Compared with GES-1, the
level of miRNA-24-3p expression was elevated in the GC
cell lines, especially in BGC823 and MGC803 (Fig. 1a).
Western blot and RT-qPCR analysis revealed that Prdx-6
expression displayed the opposite tendency as miRNA-24-
3p expression (Fig. 1b). To further examine this possible
negative relation between miRNA-24-3p and Prdx-6,
transfected SGC7901, N87, AGS, and GES-1 (cell lines
with low miRNA-24-3p expression) were transfected with
miRNA-24-3p mimics and NC mimics. Cell lines with
higher miRNA-24-3p expression (BGC823 and MGC803
cells) were transfected with miRNA-24-3p inhibitor and
NC inhibitor and, after 24 h, examined for expression of
Prdx-6. Compared with the NC group, cells transfected
with inhibitor had a 4.45-fold (BGC823) and 2.46-fold
(MGC803) increase in Prdx-6 expression (Fig. 1c). In cells
transfected with mimics, a decrease in Prdx-6 expression
was present in addition to SGC7901 (Fig. 1d). The analysis
of the Prdx-6 expression in different transfected cell lines
showed a negative regulation between miRNA-24-3p and
Prdx-6 expression.
Prdx-6 Is a Direct Target of miR-24-3p in Gastric
Cancer Cells
Though Prdx-6 has been regarded as a target of miRNA-
24-3p, it is unclear whether miRNA-24-3p can directly
recognize the 30-UTR of Prdx-6 mRNA. According to the
predicted target site from TargetScan, two luciferase
reporters were constructed: one containing a wild-type
Prdx-6 30-UTR sequence that contains the miR-24-3p
binding site (pGL3-wt-30-UTR) and another containing a
mutated Prdx-6 30-UTR (pGL3-mt-30-UTR) (Fig. 2a).
Next, luciferase reporter assays were performed to verify a
direct interaction between miR-24-3p and the 30-UTR of
Prdx-6. The luciferase reporter constructs were transfected
into N87 and AGS cells, along with miR-24-3p mimics or
negative control oligos. Compared to the NC, the relative
luciferase activity of co-transfection with miR-24-3p
mimics and the pGL3-wt-30-UTR vector decreased. How-
ever, miR-24-3p mimics did not have any effect on luci-
ferase activity when the cells were transfected with pGL3-
mt-30-UTR vector (Fig. 2b). These results suggest that the
cFig. 1 Negative regulation between miR-24-3p and Prdx-6 expres-
sion. a miR-24-3p expression in five GC cell lines and GES-1. miR-
24-3p mRNA levels were detected by RT-qPCR, compared with
GES-1, and the level of miR-24-3p expression was elevated in GC
cells, especially in BGC823 and MGC803 cell lines. b Expression of
Prdx-6 in six cell lines. Prdx-6 protein and mRNA level were detected
by RT-qPCR and Western blot analysis, respectively. Prdx-6
expression displayed the opposite tendency to miRNA-24-3p expres-
sion when examined in the same cell line. c Prdx-6 expression in
BGC823 and MGC803 cells was analyzed 24 h after transfection with
inhibitor and NC inhibitor. Inhibition of endogenous miR-24-3p
caused an increase in Prdx-6 expression. d Prdx-6 expression was
repressed by miR-24-3p in N87, AGS, and GES-1 cells. Cells were
transfected with miRNA-24-3p mimics or NC mimics; 24 h later, the
Prdx-6 expression levels were examined by RT-PCR and Western
blot analysis. Relative Prdx-6 expression was normalized against b-
actin, and data in histograms are mean relative quantity. Mean RQ
and SD are shown in each figure, and Student’s t test with SPSS
(version 11.0, IBM, USA) showed a *P\ 0.05
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Prdx-6 gene is one of the direct targets of miR-24-3p, and
miR-24-3p negatively regulates Prdx-6.
miR-24-3p Expression Is Significantly Decreased
in Response to H. pylori Infection
To explore the potential role of miR-24-3p in carcinogen-
esis related to H. pylori infection, the miR-24-3p expres-
sion level was measured in a tissue microarray. Compared
with the negative controls, ISH revealed that miR-24-3p
levels were reduced by 19.6 % in H. pylori-infected tissue
specimens. It was also found that miR-24-3p was markedly
down-regulated in CSG (50 %) relative to matched H.
pylori-non-infected tissues (95.7 %). Compared with the
GC H. Pylori-infected tissues, the level of miRNA-24-3p
expression was decreased in CAG, IM, and Dys H. Pylori-
infected tissues (Table 1).These results suggest that H.
pylori infection might contribute to a reduction in miR-24-
3p expression in vivo and miR-24-3p levels cannot reduce
H. pylori-infected tissue specimens in GC.
miR-24-3p Participates in the Development
and Progression of H. pylori-Related Gastric
Mucosal Lesions Through Negative Regulation
of Prdx-6
In order to detect Prdx-6 and miR-24-3p expression, the
same tissue microarray as well as IHC and in situ
hybridization was used. As shown in Fig. 3a, b and
Tables 2 and 3, the attenuation of miR-24-3p expression
was associated with the development of more severe gas-
tric precancerous mucosa lesions, and the expression of
miR-24-3p in gastric tumors was higher than in the adja-
cent normal mucous tissue as well as in CAG, IM, and Dys.
Contrary to these findings, Prdx-6 expression displayed the
opposite tendency when examined in the same tissue
(Fig. 3c, d; Tables 4, 5). As miR-24-3p negatively
regulated Prdx-6 as a direct regulator, it can be further
concluded that miR-24-3p as a regulator to target Prdx-6
regulates the development and progression of H. pylori-
related gastric mucosal lesions.
miR-24-3p Level Is Decreased in the Patients
with Lymph Node and Liver Metastases
The correlation of miR-24-3p with clinicopathological
characteristics was examined in 31 GC patients (Table 6).
There was no correlation between miR-24-3p expression
and patients’ age, gender, degree of differentiation or
gastric carcinoma TNM staging. However, the miR-24-3p
level was significantly decreased in the patients who had
lymph node [Fisher’s exact test (1-tail)] and liver metas-
tases [Fisher’s exact test (1-tail)]. Since miR-24-3p
expression was lowest in N87 cells, which are derived from
lymph node metastasis, this cell line was chosen for further
study.
Fig. 2 Prdx-6 is a direct target
of miRNA-24-3p in GC cells.
a The potential miR-24-3p
binding sequence of Prdx-6 30-
UTR and the mutated sequence.
b miR-24 mimics down-
regulated activity of a luciferase
reporter containing wild-type
Prdx-6 30-UTR (0.731 ± 0.09),
but not the reporter with mutant
Prdx-6 30-UTR (1.182 ± 0.34).
Student’s t test with SPSS
(version 11.0, IBM, USA)
showed a *P = 0.015
Table 1 Correlation between H. pylori infection and miR-24-3p
expression in the evolution of gastric mucosal lesions
Types of sample Number miR-24-3p positive (%)
H. pylori? H. pylori-
CSG 35 50.0 (6/12)a 95.7 (22/23)
CAG 43 27.8 (5/18)c 48 (12/25)
IM 41 26.1 (6/23)c 50.0 (9/18)
Dys 39 35.7 (10/28)c 45.5 (5/11)
GC 31 80.0 (20/25)c 83.3 (5/6)
Total 189 44.3 (47/106)b 63.9 (53/83)
a Fisher’s exact test P = 0.003 compared with CSG H. pylori (-)
b Pearson v2 test P = 0.008 compared with total H. pylori (-)
c Pearson v2 test P\ 0.005 (Bonferroni correct P value) compared
with GC H. pylori (?)
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miR-24-3p Suppresses Proliferation, Migration,
and Invasion and Promotes Apoptosis in N87 Cells
by Targeting Prdx-6 mRNA
In order to evaluate the role of miR-24-3p in the N87 cell
line, experiments were divided into five groups: Group 1,
N87 cells alone; Group 2, N87 cells stably transfected with
an empty vector; Group 3, N87 cells stably transfected with
miR-24-3p; Group 4, N87 cells transiently transfected with
Prdx-6 expression vectors overexpressing empty vector;
and Group 5, N87 cells transiently transfected with Prdx-6
expression vectors overexpressing miR-24-3p. The
expression of miR-24-3p and Prdx-6 was detected by real-
time PCR and Western blot, respectively (Fig. 4a), and the
effect of Prdx-6 on miR-24-3p-mediated cell proliferation,
apoptosis, migration, and invasion was investigated. N87
cells that had been stably transfected with miR-24-3p
(Group 3) demonstrated a lower capacity of proliferation,
migration, and invasion and a higher capacity of apoptosis
compared with cells that had been stably transfected with
the miRNA control (Group 2). These results indicate that
miR-24-3p suppresses GC cell proliferation, migration, and
invasion and promotes apoptosis. As compared with the
stably overexpressed miR-24-3p N87 cells (Group 3), the
Fig. 3 miR-24-3p participates in the development and progression of
H. pylori-related gastric mucosal lesions through negative regulation
of Prdx-6. a Attenuation of miR-24-3p expression was associated with
the development of more severe gastric precancerous mucosal lesions,
and the expression of miR-24-3p in GC was higher than in CAG, IM,
and Dys. b Expression of miR-24-3p in gastric tumors was higher
than in the adjacent normal tissue. c, d The expression of Prdx-6
displayed the opposite tendency to miR-24-3p expression in the same
tissue specimens
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proliferation, apoptosis, migration, and invasion ability of
N87 cells transiently transfected with Prdx-6 expression
vectors overexpressing miR-24-3p (Group 5) were partially
restored (Fig. 4a–f). These results indicate that miR-24-3p
overexpression mediates the suppression of proliferation,
migration, and invasion and promotes apoptosis by
inhibiting Prdx-6 expression.
Discussion
At present, more than 1900 miRNAs have been identified
in humans and they regulate the expression of about 60 %
genes in mammals [10]. miRNAs are found to be related to
a variety of cellular events, including proliferation, apop-
tosis. Moreover, miRNAs might be involved in the physi-
ological and pathological processes that contribute to the
progress of precancerous lesions to cancer [11–13]. Mor-
tality of GC patients ranks second in all malignancies [14].
Many miRNAs are closely associated with GC, but
knowledge of their abnormal expression and potential role
in GC is inadequate. Eight miRNAs (miR1274a, miR196b,
miR4298, miR181c, miR23a, miR27a, and miR-24-2) were
reported to be highly expressed in GC tissue [9]. Com-
bining this result with bioinformatics analysis on Prdx-6,
which has been intensively investigated in our previous
Table 2 miR-24-3p had higher expression in GC compared to CAG,
IM, and Dys, as determined by ISH
Types of sample Number miR-24-3p
Positive (%) Negative (%)
CSG 35 80.0 (28/35) 20.0 (7/35)
CAG 43 39.5 (17/43)a 60.5 (26/43)
IM 41 36.5 (15/41)a 63.4 (26/41)
Dys 39 38.4 (15/39)a 61.6 (24/39)
GC 31 80.6 (25/31)b 19.4 (6/31)
a Pearson v2 test P\ 0.005(Bonferroni correct P value) compared
with CSG
b Pearson v2 test P\ 0.005 (Bonferroni correct P value) compared
with CAG, IM, and Dys
Table 3 miR-24-3p had higher expression in gastric tumors com-
pared to adjacent normal tissue, as determined by ISH
Types of
sample
Number miR-24-3p expression P value
Positive (%) Negative (%)
Tumor 31 80.6 (25/31) 19.4 (6/31) \0.001
Normal 31 25.8 (8/31) 74.2 (23/31)
Table 4 Decreased Prdx-6 expression was observed in GC in com-
parison with CAG, IM, and Dys
Types of sample Number Prdx-6 expression
Positive (%) Negative (%)
CSG 35 34.3 (12/35) 65.7 (23/35)
CAG 43 83.7 (36/43)a 16.3 (7/43)
IM 41 90.3 (37/41)a 9.7 (4/41)
Dys 39 87.0 (34/39)a 13.0 (5/39)
GC 31 35.5 (11/31)b 64.5 (20/31)
a Pearson v2 test P\ 0.005(Bonferroni correct P value) compared
with CSG
b Pearson v2 test P\ 0.005 (Bonferroni correct P value) compared
with CAG, IM, and Dys
Table 5 Decreased Prdx-6 expression was observed in GC in com-
parison with adjacent normal tissue
Types of sample Number Prdx-6 expression P value
Positive (%) Negative (%)
Tumor 31 35.5 (11/31) 64.5 (20/31) \0.001
Normal 31 83.9 (26/31) 16.1 (5/31)
Table 6 Correlation between the clinicopathological characteristics









Male 23 87 (20) 13 (7) 0.161
Female 8 62.5 (5) 37.5 (3)
Age at diagnosis
C 14 71.4 (10) 28.6 (4) 0.235
\ 17 88.2 (15) 11.8 (2)
Differentiation
Moderate–well 16 75.0 (12) 25.0 (4) 0.359
Poor 15 86.7 (13) 13.3 (2)
Hepatic metastasis
Yes 12 50.0 (6) 50.0 (6) 0.001
No 19 100.0 (19) 0.0 (0)
Lymph node metastasis
Yes 13 61.5 (8) 38.5 (5) 0.034
No 18 94.4 (17) 5.6 (1)
TNM stage
I–II 11 72.7 (8) 27.3 (3) 0.354
III–IV 20 85.0 (17) 15.0 (3)
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Fig. 4 miR-24-3p suppresses proliferation, migration, and invasion
and promotes apoptosis of N87 cells by targeting Prdx-6. a miR-24-
3p was overexpressed in Group 3 and Group 5, Prdx-6 expression in
Group 5 was equal to Group 2, and Prdx-6 expression was lowest in
Group 3. b Cell proliferation was analyzed by MTT assay in N87
cells. Growth curve is shown for each group at 0, 24, 48, 72, and 96 h.
c Representative micrographs and histograms depicting apoptosis of
N87 cells in each group after 24 and 48 h. d, e Representative fields
of N87 cells in migration and invasion assays, respectively. Gastric
cancer cell proliferation, apoptosis, migration, and invasion are
restored after Prdx-6 restoration. Average number of cells per field
from three independent experiments is presented as data in his-
tograms. Data are presented as mean ± SD or percentage, and means
and SD are shown in the bottom of the figure, and Student’s t test with
SPSS (version 11.0, IBM, USA) showed a *P\ 0.05
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Fig. 4 continued
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study [8], we selected miR-24-3p for further study. To
explore the negative regulation between miR-24-3p and
Prdx-6, the expression of miR-24-3p and Prdx-6 in GES-1
and GC cell lines was examined; then, miR-24-3p mimics,
miR-24-3p inhibitor, and negative control were transiently
transfected into these cell lines and a negative association
between miR-24-3p and Prdx-6 expression was identified
in all GC cell lines, except SGC7901. In addition, it was
confirmed by a luciferase reporter assay that miR-24-3p
directly targets the binding sites in the 30-UTR of Prdx-6
and represses Prdx-6 protein expression; Prdx-6 gene is one
of the direct targets of miR-24-3p. Although a negative
association between miR-24-3p and Prdx-6 expression
levels was observed in the liver metastasis cell of gastric
adenocarcinoma SGC7901, overexpressing miR-24-3p did
not decrease the expression of Prdx-6. Since miRNA can
regulate several target genes and several miRNAs can
coordinate regulation of the same gene, further study is
needed to uncover the underlying mechanism in SGC7901.
GC is the final stage of H. pylori-related chronic gastric
mucosal lesions, which develops from normal mucosa to
CSG, CAG, IM, Dys, and finally to GC [15]. H. Pylori-
induced oxidative DNA damage occurs in all phases of this
multistep process. In this study, the expression of miR-24-
3p was found to decrease along with the progression of
precancerous gastric mucosa lesions and miR-24-3p was
found to play a part in H. pylori-related gastric mucosal
lesions by negative regulation of Prdx-6. These results
demonstrate that expression of the Prdx-6 gene is promoted
by a decreased expression of miR-24-3p, resulting in
reduced ROS-induced gastric mucosal injury and preven-
tion of lesion progression. Furthermore, our data provide
evidence of higher miR-24-3p expression level in GC tis-
sues compared to corresponding nontumor normal tissues
and miR-24-3p levels cannot reduce H. pylori-infected
tissue specimens in GC. The reason for this phenomenon is
that with progression of gastric mucosal lesions to GC,
ROS was overproduced and miR-24-3p expression was no
longer decreased, causing imbalance of the oxidative–an-
tioxidant system. The imbalanced system, in turn, creates
feedback that leads to an increased miR-24-3p expression
and decreased Prdx-6 expression.
The 5-year survival rate of early diagnosed GC patients
is higher than 90 %, while it is only 30-40 % for advanced
GC [16, 17]. Our data suggest that miR-24-3p level is
dynamically changed in the development and progression
of gastric mucosal lesion and related to GC lymph node
metastasis, indicating that miR-24-3p can be potentially
used for early diagnosis and as a tumor molecular marker
to assess the stage of gastric mucosal lesions and lymph
node and liver metastasis. There are several limitations in
our study. First, the number of samples and cell lines
analyzed and validated was not enough. Second, the
follow-up data were short, and we cannot get the exact
conclusion that miR-24-3p is related to the prognosis.
Conclusions
The 5-year survival rate of early diagnosed GC patients is
higher than 90 %, while it is only 30–40 % for advanced
GC [16, 17]. Our data suggest that miR-24-3p level is
dynamically changed in the development and progression
of gastric mucosal lesion and related to GC lymph node
metastasis, indicating that miR-24-3p can be potentially
used for early diagnosis and as a tumor molecular marker
to assess the stage of gastric mucosal lesions and lymph
node and liver metastasis.
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